JANSSEN-CILAG LIMITED

Active Buckinghamshire

Manufacture of pharmaceutical preparations

1,090 employees website.com
Manufacture of pharmaceutical preparations
J

JANSSEN-CILAG LIMITED

Manufacture of pharmaceutical preparations

Founded 19 Oct 1971 Active Buckinghamshire, United Kingdom 1,090 employees website.com
Manufacture of pharmaceutical preparations

Previous Company Names

JANSSEN PHARMACEUTICAL LIMITED 19 Oct 1971 — 1 Jan 1995
Accounts Submitted 3 Nov 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 16 Jan 2026 Next due 24 Jan 2027 8 months remaining
Net assets £248M £47M 2024 year on year
Total assets £523M £70M 2024 year on year
Total Liabilities £275M £23M 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG

Website

www.example.com

Full company profile for JANSSEN-CILAG LIMITED (01027904), an active company based in Buckinghamshire, United Kingdom. Incorporated 19 Oct 1971. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2013–2024)

Cash in Bank

£2.80M

Decreased by £16.69M (-86%)

Net Assets

£247.83M

Increased by £46.76M (+23%)

Total Liabilities

£275.39M

Increased by £23.14M (+9%)

Turnover

£637.41M

Decreased by £15.81M (-2%)

Employees

1090

Decreased by 1 (-0%)

Debt Ratio

53%

Decreased by 3 (-5%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (2)

Jjhc, Llc
100.0%
239,998
Johnson & Johnson International
0.0%
2

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Johnson & Johnson

Unknown

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

JANSSEN-CILAG LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Apr 2026OfficersAppointment of Ms Maria Alexandra Gomez Lora as director on 18 Mar 2026
16 Jan 2026Confirmation StatementConfirmation statement made on 10 Jan 2026 with updates
9 Jan 2026OfficersTermination of David Geelan as director on 9 Jan 2026
6 Jan 2026OfficersTermination of Shelagh Mary Anderson as director on 30 Dec 2025
3 Nov 2025AccountsAnnual accounts made up to 29 Dec 2024
2 Apr 2026 Officers

Appointment of Ms Maria Alexandra Gomez Lora as director on 18 Mar 2026

16 Jan 2026 Confirmation Statement

Confirmation statement made on 10 Jan 2026 with updates

9 Jan 2026 Officers

Termination of David Geelan as director on 9 Jan 2026

6 Jan 2026 Officers

Termination of Shelagh Mary Anderson as director on 30 Dec 2025

3 Nov 2025 Accounts

Annual accounts made up to 29 Dec 2024

Recent Activity

Latest Activity

Appointment of Ms Maria Alexandra Gomez Lora as director on 18 Mar 2026

1 months ago on 2 Apr 2026

Confirmation statement made on 10 Jan 2026 with updates

3 months ago on 16 Jan 2026

Termination of David Geelan as director on 9 Jan 2026

4 months ago on 9 Jan 2026

Termination of Shelagh Mary Anderson as director on 30 Dec 2025

4 months ago on 6 Jan 2026

Annual accounts made up to 29 Dec 2024

6 months ago on 3 Nov 2025